The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
Overview of attention for article published in American Journal of Clinical Pathology, January 2011
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (78th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (64th percentile)
Readers on
- mendeley
- 46 Mendeley